News

ABSANZ 2023
Suncombe will be attending ABSANZ 2023, the annual conference of the Association of Biosafety for Australia and New Zealand (ABSANZ).

Hosokawa Micron new sales agent in the Netherlands
Suncombe is pleased to announce the appointment of Hosokawa Micron as its new sales agent in the Netherlands.

Suncombe EDSbatch® Press Release
Suncombe EDSPlus™ range of effluent decontamination systems upgraded with sustainability and efficiency improvements and renamed EDSbatch®

Chemical Engineering Nov 2022
Chemical Engineering press release November 2022 highlighting Suncombe’s updated GMP Water Heating Skids.

Sustainable Water Heater Adds Electric Functionality
Labmate press release reporting Suncombe’s global release of the updated GMP Water Heating Skids.

Industrial Process News – Company of the Month
Suncombe celebrates sixty years of continuous development cleaning and critical process systems. Industrial Process News press release.

EBSA 2022
Suncombe exhibited at the EBSA 2022, the annual conference of the European Biosafety Association.

Pre-validated bioprocess vessels and CIP systems combine for hybrid single use facilities
Suncombe, the cleaning and critical process systems specialists, has announced the global release of the PureVessel™ range of systems.

Time critical delivery of biowaste decontamination systems
Suncombe has designed, built and delivered high specification biowaste effluent decontamination systems (EDS) in an extremely short timeframe to support the expanding Covid-19 vaccine production programme

MicroEDS ™ Spanish Press Release
MicroEDS ™ Effluent Decontamination System – Press Release available in Spanish A Spanish version of the datasheet is now available.

Suncombe MicroEDS ® July 2021
Suncombe has announced the global release of the MicroEDS® BioWaste Treatment System for biologically hazardous waste decontamination

Amazing Turnaround on Utility Panels for Vaccine Manufacturer
Suncombe recently commissioned to help develop a set of Utility Panels for an extremely fast turnaround for a COVID-19 vaccine manufacturer